Sucampo Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to develop some of their medical products and clinical analysis.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“RTU-009 is a pre-clinical stage, injectable VAP-1 inhibitor that is being studied in animal models of acute cerebral infarction.” (Page 10) Read the full document
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on research and development of drugs to treat gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It operates through development and commercialization of pharmaceutical products segment. [Source: Reuters]
Company Website: http://www.sucampo.com